Xtant Medical Holdings, Inc. (XTNT) |
| 0.45 0.007 (1.58%) 07-17 16:00 |
| Open: | 0.4393 |
| High: | 0.475 |
| Low: | 0.41 |
| Volume: | 136,498 |
| Market Cap: | 63(M) |
| PE Ratio: | 43.27 |
| Exchange: | New York Stock Exchange American |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.57 |
| Resistance 1: | 0.49 |
| Pivot price: | 0.43 |
| Support 1: | 0.43 |
| Support 2: | 0.39 |
| 52w High: | 0.95 |
| 52w Low: | 0.39 |
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 16 Jul 2026
XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - ad-hoc-news.de
Thu, 16 Jul 2026
SemiLEDs And 2 Other Promising Penny Stocks To Watch - Sahm
Mon, 06 Jul 2026
Xtant Medical Holdings (XTNT) Edges Higher Near Key Support at $0.40 - Volatility Smile - dars.gov.et
Fri, 03 Jul 2026
Xtant Medical Holdings (XTNT) Pressures Support at $0.39 After 1.67% Decline - Low Vol ETF - dars.gov.et
Thu, 07 May 2026
May 13 before trading: Xtant Medical posts Q1 results, 8:30 ET call - Stock Titan
Wed, 06 May 2026
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |